Formed Bone (formed + bone)

Distribution by Scientific Domains

Kinds of Formed Bone

  • newly formed bone


  • Selected Abstracts


    Bone repair in mandibular body osteotomy after using 2.0 miniplate system , histological and histometric analysis in dogs

    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Issue 2 2008
    Cássio Edvard Sverzut
    Summary The objective of this study was to evaluate the bone repair along a mandibular body osteotomy after using a 2.0 miniplate system. Nine adult mongrel dogs were subjected to unilateral continuous defect through an osteotomy between the mandibular 3rd and 4th premolars. Two four-hole miniplates were placed in accordance with the Arbeitgeimeinschaft für Osteosynthesefragen Manual. Miniplates adapted to the alveolar processes were fixed monocortically with 6.0-mm-length titanium alloy self-tapping screws, whereas miniplates placed near the mandible bases were fixed bicortically. At 2, 6 and 12 weeks, three dogs were sacrificed per period, and the osteotomy sites were removed, divided into three thirds (Tension Third, TT; Intermediary Third, IT; Compression Third, CT) and prepared for conventional and polarized light microscopy. At 6 weeks, while the CT repaired faster and showed bone union by woven bone formation, the TT and IT exhibited a ligament-like fibrous connective tissue inserted in, and connecting, newly formed woven bone overlying the parent lamellar bone edges. At 12 weeks, bone repair took place at all thirds. Histometrically, proportions of newly formed bone did not alter at TT, IT and CT, whereas significantly enhanced bone formation was observed for the 12-week group, irrespective of the third. The results demonstrated that although the method used to stabilize the mandibular osteotomy allowed bone repair to occur, differences in the dynamics of bone healing may take place along the osteotomy site, depending on the action of tension and compression forces generated by masticatory muscles. [source]


    Bone regeneration in rabbit sinus lifting associated with bovine BMP

    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2004
    Sergio Allegrini Jr.
    Abstract Autogenous bone is considered the optimal grafting material for sinus lifting, although its harvesting causes great patient discomfort. Various approaches have been taken in order to obtain sinus lifting with preexisting tissue. However, because of the unsuitability of such tissue, additional materials have been required. Alternatively, biomaterials from humans or other animals are used. In this study, the efficacy of using morphogenetic bovine bone protein (BMPb) to augment the maxillary sinus floor was examined. Four grafting materials were employed: lyophilized bovine bone powder, absorbable collagen flakes, natural hydroxylapatite, and synthetic hydroxylapatite. Two groups of rabbits were studied. In one group, graft material only was used. In the other, graft material was combined with 0.5 mg BMPb. During 8 weeks of observation, polyfluorochrome tracers were injected in subcutaneous tissue to evaluate new bone- deposition periods. Following sacrifice, the samples were examined under fluorescent and light microscopes. Results indicated 33.34% more newly formed bone in BMPb animals than in controls. Graft-material resorption increased, but natural HA showed no significant alterations. The results show that the use of BMPb, although providing osteoinduction, might not promote sufficient bone formation. Nonetheless, this material could provide an alternative to autogenous grafts, thereby avoiding patient discomfort. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 68B: 127,131, 2004 [source]


    Behavior of dense and porous hydroxyapatite implants and tissue response in rat femoral defects

    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 1 2002
    J.C.T. Andrade
    Abstract Porous and dense hydroxyapatite cylinders (PHA and DHA) were implanted into cavities produced in rat femora and the sites of implantation were examined at different times over a period of 24 weeks by microradiologic and histological techniques. Microradiographs showed the presence of a layer of trabecular bone around the implants, which became more radiopaque and thinner along the experimental time. The microradiologic methodology used was suitable for the evaluation of the interface between hydroxyapatite and newly formed bone in nondecalcified materials. Microscopic observations showed that young bone grew over the surface of both types of implants after 1 and 2 weeks of surgery and that bone also grew inside PHA implants. Progressive bone absorption was observed in both types of implants after the fourth week. A layer of fibrous tissue was formed in the interface between new bone and DHA. Mature bone with haversian systems surrounded DHA implants and filled the pores of PHA implants throughout the experimental period. The pores of PHA implants were smaller than those commonly reported, which should have been a disadvantage, although it was observed that the extra cellular fluid induced disintegration of the ceramic granules, allowing the gradual growth of bone tissue into the spaces among them, without the interposition of fibrous tissue. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 62: 30,36, 2002 [source]


    In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes

    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 6 2001
    Anita A. Ignatius
    Abstract Porous composites made of poly(L, DL-lactide) (PLA) and ,-tricalcium phosphate (,-TCP) or the glass ceramic, GB14N, respectively, were investigated in a loaded implant model in sheep. Six, 12 and 24 months after implantation histological and biomechanical evaluation were performed and compared to autogenous bone transplants. No significant differences were observed between the composites. After 6 months, the interconnecting pores of the ,-TCP-composite and the GB14N-composite were filled with newly formed bone (14 ± 5% or 29 ±15% of the implant, respectively) and soft tissue (30 ±9% or 21 ±12% of the implant, respectively). Only a mild inflammatory response was observed. The reaction was similar after 12 months. However, after 24 months a strong inflammatory reaction was seen. The newly formed bone was partly osteolytic. The adverse reaction occurred simultaneously to a significant reduction of the PLA component. The histological results were reflected by the biomechanical outcomes. Both composites showed compression strengths in the range of the autologous bone graft until 12 months of implantation. After 2 years, however, the strengths were significantly decreased. It is concluded that the new composites cannot yet be used for clinical application. An improvement in biocompatibility might be reached by a better coordination of the degradation times of the polymer and the ceramic component. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res (Appl Biomater) 58: 701,709, 2001 [source]


    In Vivo RANK Signaling Blockade Using the Receptor Activator of NF-,B:Fc Effectively Prevents and Ameliorates Wear Debris-Induced Osteolysis via Osteoclast Depletion Without Inhibiting Osteogenesis

    JOURNAL OF BONE AND MINERAL RESEARCH, Issue 2 2002
    Lisa M. Childs
    Abstract Prosthesis failure due to wear debris-induced osteolysis remains a major clinical problem and the greatest limitation for total joint arthroplasty. Based on our knowledge of osteoclast involvement in this process and the requirements of receptor activator of NF-,B (RANK) signaling in osteoclastogenesis and bone resorption, we investigated the efficacy of RANK blockade in preventing and ameliorating titanium (Ti)-induced osteolysis in a mouse calvaria model. Compared with placebo controls we found that all doses of RANK:Fc above 1 mg/kg intraperitoneally (ip) per 48 h significantly inhibited osteoclastogenesis and bone resorption in response to Ti implanted locally. Complete inhibition occurred at 10 mg/kg ip per 48 h, yielding results that were statistically equivalent to data obtained with Ti-treated RANK,/, mice. We also evaluated the effects of a single injection of RANK:Fc on day 5 on established osteolysis and found that Ti-treated were still depleted for multinucleated tartrate-resistant acid phosphatase-positive (TRAP+) cells 16 days later. More importantly, this osteoclast depletion did not affect bone formation because the bone lost from the osteolysis on day 5 was restored by day 21. An assessment of the quantity and quality of the newly formed bone in these calvariae by calcein labeling and infrared (IR) microscopy, respectively, showed no significant negative effect of RANK:Fc treatment. These studies indicate that osteoclast depletion via RANK blockade is an effective method to prevent and reverse wear debris-induced osteolysis without jeopardizing osteogenesis. [source]


    Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 8 2010
    Giuseppe Polimeni
    Polimeni G, Wikesjö UME, Susin C, Qahash M, Shanaman RH, Prasad HS, Rohrer MD, Hall J. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations. J Clin Periodontol 2010; 37: 759-768 doi: 10.1111/j.1600-051X.2010.01579.x. Abstract Objectives: In vitro and in vivo preclinical studies suggest that growth/differentiation factor-5 (GDF-5) may induce local bone formation. The objective of this study was to evaluate the potential of recombinant human GDF-5 (rhGDF-5) coated onto an oral implant with a purpose-designed titanium porous oxide surface to stimulate local bone formation including osseointegration and vertical augmentation of the alveolar ridge. Materials and Methods: Bilateral, critical-size, 5 mm, supraalveolar peri-implant defects were created in 12 young adult Hound Labrador mongrel dogs. Six animals received implants coated with 30 or 60 ,g rhGDF-5, and six animals received implants coated with 120 ,g rhGDF-5 or left uncoated (control). Treatments were alternated between jaw quadrants. The mucoperiosteal flaps were advanced, adapted, and sutured to submerge the implants for primary intention healing. The animals received fluorescent bone markers at weeks 3, 4, 7, and 8 post-surgery when they were euthanized for histologic evaluation. Results: The clinical examination showed no noteworthy differences between implants coated with rhGDF-5. The cover screw and implant body were visible/palpable through the alveolar mucosa for both rhGDF-5-coated and control implants. There was a small increase in induced bone height for implants coated with rhGDF-5 compared with the control, induced bone height averaging (±SD) 1.6±0.6 mm for implants coated with 120 ,g rhGDF-5 versus 1.2±0.5, 1.2±0.6, and 0.6±0.2 mm for implants coated with 60 ,g rhGDF-5, 30 ,g rhGDF-5, or left uncoated, respectively (p<0.05). Bone formation was predominant at the lingual aspect of the implants. Narrow yellow and orange fluorescent markers throughout the newly formed bone indicate relatively slow new bone formation within 3,4 weeks. Implants coated with rhGDF-5 displayed limited peri-implant bone remodelling in the resident bone; the 120 ,g dose exhibiting more advanced remodelling than the 60 and 30 ,g doses. All treatment groups exhibited clinically relevant osseointegration. Conclusions: rhGDF-5-coated oral implants display a dose-dependent osteoinductive and/or osteoconductive effect, bone formation apparently benefiting from local factors. Application of rhGDF-5 appears to be safe as it is associated with limited, if any, adverse effects. [source]


    Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): radiographic observations

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 10 2008
    Knut N. Leknes
    Abstract Aim: The objective of this study was to radiographically evaluate the potential of a purpose-designed titanium porous-oxide implant surface coated with recombinant human bone morphogenetic protein-7 (rhBMP-7), also known as recombinant human osteogenic protein-1 (rhOP-1), to stimulate alveolar ridge augmentation. Material and Methods: Six young-adult Hound Labrador mongrel dogs were used. Three 10 mm titanium oral implants per jaw quadrant were placed 5 mm into the alveolar ridge in the posterior mandible following surgical extraction of the pre-molar teeth and reduction of the alveolar ridge leaving 5 mm of the implants in a supra-alveolar position. The implants had been coated with rhBMP-7 at 1.5 or 3.0 mg/ml and were randomized to contralateral jaw quadrants using a split-mouth design. The mucoperiosteal flaps were advanced, adapted, and sutured to submerge the implants. Radiographic registrations were made immediately post-surgery (baseline), and at weeks 4 and 8 (end of study). Results: rhBMP-7-coated implants exhibited robust radiographic bone formation. At 8 weeks, bone formation averaged 4.4 and 4.2 mm for implants coated with rhBMP-7 at 1.5 and 3.0 mg/ml, respectively. There were no significant differences between the rhBMP-7 concentrations at any observation interval. A majority of the implant sites showed voids within the newly formed bone at week 4 that generally resolved by week 8. The newly formed bone assumed characteristics of the resident bone. Conclusions: The titanium porous-oxide implant surface serves as an effective carrier for rhBMP-7 showing a clinically significant potential to stimulate local bone formation. [source]


    The amount of newly formed bone in sinus grafting procedures depends on tissue depth as well as the type and residual amount of the grafted material

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 2 2005
    Zvi Artzi
    Abstract Objectives: Bone replacement substitutes are almost unavoidable in augmentation procedures such as sinus grafting. The objective of the present study was to evaluate the osteoconductive capability of two different scaffold fillers in inducing newly formed bone in this procedure. Material and Methods: Sinus floor augmentation and implant placement were carried out bilaterally in 12 patients. Bovine bone mineral (BBM) was grafted on one side and , -tricalcium phosphate (, -TCP) on the contralateral side. Both were mixed (1:1 ratio) with autogenous cortical bone chips harvested from the mandible by a scraper. Hard tissue specimen cores were retrieved from the augmented sites (at the previous window area) at 12 months. Decalcified sections were stained with haematoxylin,eosin and the fraction area of new bone and filler particles was measured. In addition to the effect of the filler on new bone formation, the latter was tested to determine whether it correlated with the tissue depth and residual amount of the grafted material. Results: Bone area fraction increased significantly from peripheral to deeper areas at both grafted sites in all cores: from 26.0% to 37.7% at the , -TCP sites and from 33.5% to 53.7% at the BBM-grafted sites. At each depth the amount of new bone in BBM sites was significantly greater than that in TCP sites. However, the average area fraction of grafted material particles was similar in both fillers and all depth levels (, -TCP=27.9,23.2% and BBM=29.2,22.6%, NS). A significant negative correlation was found between bone area fraction and particle area fraction at the middle (p=0.009) and deep (p=0.014) depths in the , -TCP sites, but not at the BBM sites. Conclusion: At 12 months post-augmentation, the two examined bone fillers, , -TCP and BBM, promoted new bone formation in sinus grafting but the amount of newly formed bone was significantly greater in BBM-grafted sites. However, both exhibited similar residual grafted material area fraction at this healing period. This could imply that BBM possesses better osteoconductive properties. [source]


    Gentamicin used as an adjunct to GTR

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 5 2003
    An experimental study in rats
    Abstract Objectives: To evaluate in a discriminating "capsule" model whether local application of gentamicin may have an added effect on bone formation produced by Bio-Oss® and guide tissue regeneration (GTR). Material and Methods: Thirty male 3-month-old Wistar rats were used. After elevation of muscle-periosteal flaps, a rigid hemispherical Teflon capsule, loosely packed with 0.025 g of Bio-Oss® impregnated with 2 mg/ml gentamicin sulfate (Garamycin®), was placed with its open part facing the lateral bone surface of the mandibular ramus (test) in one side of the jaw. A capsule filled only with Bio-Oss® (control) was placed on the contralateral side of the jaw. After healing periods of 1, 2 and 4 months, groups of 10 animals were sacrificed and the specimens were processed for histological examination. The volumes of (1) the space created by the capsule, (2) newly formed bone, (3) Bio-Oss® particles, (4) loose connective tissue, and (5) acellular space in the capsule were estimated by a point-counting technique in three to four histological sections of each specimen, taken by uniformly random sampling. Results: The histological evaluation showed limited but increasing bone fill in the capsules from 1 to 4 months in both the test and control sides. After 4 months, the newly formed bone occupied 11.9% (CV: 0.39) of the space created by the capsules at the test sides versus 13.2% (CV: 0.41) at the control sides. There was no statistical significant difference between test and control specimens at any observation time (p>0.05). Conclusion: It is concluded that local application of gentamicin has no added effect on bone formation when combined with Bio-Oss® and GTR. Zussamenfassung Gentamycin als Adjunktiv zur GTR genutzt. Eine experimentelle Studie bei Ratten Ziele:Überprüfung in einem "unterscheidenden" Kapselmodell, ob die lokale Applikation von Gentamycin einen zusätzlichen Effekt bei der Knochenbildung, die durch Bio-Oss® bei der GTR hervorgerufen wurde, hat. Material und Methoden: 30 männliche 3monatige Wistar-Ratten wurden genutzt. Nach der Elevation von Muskel-Periost-Lappen wurde eine rigide halbsphärische Teflonkapsel, die locker mit 0,025 g von Bio-Oss®, was mit Gentamycinsulfat 2mg/ml (Garamycin®) imprägniert war, auf einer Seite des Unterkieferramus (Test) so platziert, dass der offene Teil zur lateralen Knochenoberfläche gerichtet war. Eine Kapsel, die nur mit Bio-Oss gefüllt war (Kontrolle), wurde auf der kontralateralen Seite des Kiefers platziert. Nach der Heilungsperiode von 1, 2 und 4 Monaten wurden Gruppen von 10 Tieren getötet und die Proben für die histologische Überprüfung aufbereitet. Das Volumen von 1) dem Spalt, der durch die Kapsel geschaffen wurde, 2) dem neu gebildeten Knochen, 3) den Bio-Oss Partikeln, 4) dem lockeren Bindegewebe und 5) dem azellulären Spalt in der Kapsel wurden mit einer Punktzähltechnik in 3 bis 4 histologischen Schnitten von jeder Probe unter Nutzung einer allgemeinen Zufallsauswahl bestimmt. Ergebnisse: Die histologische Überprüfung zeigte eine limitierte aber zunehmende Knochenfüllung in der Kapsel vom 1. zum 4. Monat sowohl in der Test- als auch der Kontrollseite. Nach 4 Monaten besetzte der neu gebildete Knochen 11,9% (cv: 0,39) des von der Kapsel geschaffenen Spaltes bei den Testseiten verglichen mit 13,2% (cv: 0,41) bei den Kontrollseiten. Es gab keine statistisch signifikante Differenz zwischen Test- und Kontrollproben zu irgendeiner Beobachtungszeit (p>0,05). Schlussfolgerung: Es wird geschlossen, dass die lokale Applikation von Gentamycin keinen zusätzlichen Effekt auf die Knochenbildung hat, wenn eine Kombination mit Bio-Oss und der GTR erfolgt. Résumé La gentamycine utilisée en association à la GTR. Une étude expérimentale chez le rat Le but de cette étude a été d'évaluer si l'application locale de gentamycine dans un modèle de capsule discriminatoire pouvait avoir un effet additionnel bénéfique sur la formation osseuse produite par le Bio-Oss® et la GTR. Cette étude a eu recours à trente rats Wistar mâles de trois mois. Après l'élévation de lambeaux muscle-périoste, une capsule en téflon hémisphérique rigide, remplie de manière lâche avec 0,025 g de Bio-Oss® imprégnée avec 2mg/ml de sulfate de gentamycine (Garamycin®) a été placée avec sa face ouverte en regard de la surface osseuse latérale de la branche mandibulaire (test) d'un côté de la mâchoire. Une capsule remplie uniquement de Bio-Oss® (contrôle) a été placée dans le site contralatéral. Après des périodes de guérison de un, deux et quatre mois, des groupes de dix animaux ont été tués et les spécimens analysés histologiquement. Les volumes de 1) l'espace créé par la capsule, 2) l'os néoformé, 3) les particules de Bio-Oss®, 4) le tissu conjonctif lâche et 5) l'espace acellulaire dans la capsule ont été estimés par la technique de comptage par points dans trois à quatre coupes histologiques de chaque échantillon, pris de manière uniformément et randomisée. L'évaluation histologique a montré une augmentation limitée d'os dans les caspsules de un à quatre mois tant dans les sites tests que contrôles. Après quatre mois l'os néoformé occupait 11,9% (cv : 0,39) de l'espace créé par les capsules au niveau des sites tests vs 13,2% (cv : 0,41) au niveau des contrôles. Il n'y avait aucune différence statistique entre les échantillons tests et contrôles à aucun des temps d'observation (p>0,05). L'application locale de gentamycine n'aurait donc aucun effet sur la formation osseuse lorsqu'elle est placée avec le Bio-Oss® en association avec la GTR. [source]


    Osteogenesis by guided tissue regeneration and demineralized bone matrix

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 3 2003
    N. Mardas
    Abstract Aim:, To evaluate in a discriminating capsule model whether bone formation by guided tissue regeneration (GTR) may be influenced by concomitant implantation of demineralized bone matrix (DBM). Materials and Methods:, Thirty 4-month-old male albino rats of the Wistar strain were used in the study. Following surgical exposure of the mandibular ramus, a hemispherical, Teflon capsule (5.0 mm in diameter), loosely packed with a standardized amount of DBM, was placed with its open part facing the lateral bone surface of the ramus. At the contralateral side, an empty capsule was placed, serving as control. After healing periods of 15, 30, and 120 days, groups of 10 animals were sacrificed and 40,70 ,m thick undecalcified sections of the capsules were produced. In the sections, the cross-sectional areas of (1) the space created by the capsule, (2) newly formed bone, (3) DBM particles, (4) loose connective tissue as well as the (5) height of the capsules, and (6) that of the newly formed bone were measured. Results:, Increasing bone fill was observed in both test and control sites from 30 to 120 days. After 30 days of healing, the mean amount of bone was approx. 3% of the cross-sectional area of the capsules at the test sites while it was 8% in the control sites (p<0.05). However, no statistically significant differences were observed between the test (46%) and control (64%) sites after 120 days regarding any of the measured parameters (p>0.05). The newly formed bone in the DBM group at 120 days, on the other hand, appeared more dense than that in the control capsules. Conclusion:, DBM used as an adjunct to GTR did not provide any added effect on bone formation but increased the density of the newly formed bone. Zusammenfassung Ziel: Die Untersuchung in einem Kapselmodell, welches differenzieren kann, ob die Knochenbildung durch GTR durch die gleichzeitige Implantation von demineralisierter Knochenmatrix (DBM) beeinflusst werden könnte Material und Methoden: Dreißig männliche 4-Monate-alte Albinoratten des Wistar Stammes wurden in der Studie verwendet. Nach der chirurgischen Freilegung des Unterkieferastes wurde eine halbkugelförmige Teflonkapsel (5,0 mm Durchmesser), welche locker mit einer standardisierten Menge von DBM versehen war, wurde mit ihrer offenen Fläche auf die seitlichen Knochenfläche des Ramus gelegt. Auf der kontralateralen Seite diente eine leere Kapsel als Kontrolle. Nach Heilungsintervallen von 15, 30 und 120 Tagen wurden Gruppen von 10 Tieren geopfert und 40-70 ,m dicke nicht-entkalkte Schnitte der Kapseln wurden hergestellt. An den Schnitten wurde die Querschnittsfläche von: 1) der Fläche, die von der Kapsel geschaffen wurde, 2) dem neu gebildeten Knochen, 3) den DBM-Partikeln, 4) dem lockeren Bindegewebe gemessen, als auch 5) die Höhe der Kapseln und 6) des neu gebildeten Knochens bestimmt. Ergebnisse: Von Tag 30 zu Tag 120 wurde sowohl bei den Test- als auch bei den Kontrollstellen eine erhöhte Knochenauffüllung beobachtet. Nach 30 Tagen der Heilung betrug an den Teststellen die mittlere Knochenmenge ungefähr 3% der Querschnittsfläche der Kapseln, während sie an den Kontrollstellen 8% (p<0,05) betrug. Jedoch wurde nach 120 Tagen bei keinem der gemessenen Parameter eine statistisch signifikante Differenz zwischen den Test- (46%) und den Kontrollstellen (64%) beobachtet. Auf der anderen Seite erschien nach 120 Tagen in der DBM-Gruppe der neu gebildete Knochen dichter als in den Kontrollkapseln Schlussfolgerung: DBM welches als Zusatz bei der GTR verwendet wurde, lieferte keinen zusätzlichen Effekt bei der Knochenbildung, aber erhöhte die Dichte des neu gebildeten Knochens. Résumé Le but de cette étude a été d'évaluer dans un modèle de capsule discriminatoire si la formation osseuse par regénération tissulaire guidée (GTR) pouvait être influencée par l'implantation concomitante de matrice osseuse déminéralisée (DBM). Trente rats albinos mâles âgés de quatre mois de la souche Wistar ont été utilisés pour cette étude. A la suite de l'exposition chirurgicale de la branche montante mandibulaire, une capsule en téflon hémisphérique de 0,5 mm de diamètre remplie sans tassement avec une quantité standardisée de DBM a été placée avec sa partie ouverte contre la surface osseuse latérale de la branche. Du côté contralatéral, une capsule vide était placée servant de contrôle. Après des périodes de guérison de 15, 30 et 120 jours, des groupes de dix animaux ont été tués et des coupes non-décalcifiées de 40 à 70 ,m d'épaisseur des capsules ont été effectuées. Dans ces coupes, une aire sur coupe transversale contenant 1) l'espace créé par la capsule, 2) l'os néoformé, 3) des particules DBM, 4) du tissu conjonctif lâche; 5) la hauteur des capsules et 6) et celle de l'os néoformé ont été mesurés. Un comblement osseux de plus en plus important tant dans les sites contrôles que les sites tests a été constaté entre les jours 30 et 120. Après 30 jours de guérison, la quantité moyenne d'os formait approximativement 3% de l'aire de la coupe des capsules dans les sites tests tandis qu'elle était de 8% dans les sites contrôles (p<0,05). Cependant, aucune différence statistique n'a été observée entre les sites tests (46%) et les sites contrôles (64%) après 120 jours pour les paramètres mesurés (p>0,05). L'os néoformé dans le groupe DBM à 120 jours semblait plus dense que dans les capsules contrôles. Le DBM utilisé durant la GTR n'apportait aucun effet additionnel sur la formation osseuse mais augmentait cependant la densité du nouvel os formé. [source]


    Deproteinized cancellous bovine bone (Bio-Oss®) as bone substitute for sinus floor elevation

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 3 2003
    A retrospective, histomorphometrical study of five cases
    Abstract Objectives: To study in detail the performance of deproteinized cancellous bovine bone (DPBB, Bio-Osso®) granules as a bone substitute, a histomorphometric was performed on five patients treated with DPBB for reconstruction of the severely atrophic maxilla. Material and Methods: DPBB was used as mixture with autogenous bone particles, in concentrations that increased from 20% to 100% DPBB, with the time of healing increasing accordingly from 5 to 8 months. A total of 20 vertical biopsies was taken at the time of fixture installation and used for histomorphometry as undecalcified Goldner stained sections. Results: The results show that in all cases, the DPBB granules had been interconnected by bridges of vital newly formed bone. The volume of bone in the grafted area correlated inversely with the concentration of DPBB grafted, and varied between 37% and 23%. However, the total volume of mineralized material (bone plus DPI3B granules) remained within the same range in all five patients (between 53% and 59%). The high values for osteoid and resorption surface, and the presence of tartrate-resistant acid phosphatase-positive multinucleated osteoclasts in resorption lacunae, indicated that bone remodeling was very active in all grafts. Osteoclasts were also observed in shallow resorption pits on DPBB surfaces. The percentage DPBB surface in contact with bone remained stable at about 35% and could not be related to the proportion of DPBB grafted. Conclusion: Although the number of patients examined was limited, the data suggest that deproteinized cancellous bovine bone, preferably combined with autogenous bone particles, is a suitable material for sinus floor elevation in the severely atrophic human maxilla. Zusammenfassung Ent-Proteinisierter spöngiöser boviner Knochen (Bio-Oss) als Knochenersatz zur Sinusboden-Elevation. Eine retrospektive histomorphometrische Studie an 5 Fällen. Ziele:Um das Verhalten Ent-Proteinisierten spöngiösen bovinen Knochengranulats (DPBB, Bio,Oss) als Knochenersatzmaterial detailliert zu studieren, wurde an 5 Patienten, die mit DPBB zur Rekonstruktion der stark atrophischen Maxilla behandelt wurden, eine histomorphometrische Studie durchgeführt. Material und Methoden:DPBB wurde als Mischung mit autogenen Knochenpartikeln in einer Konzentration von 20 , 100% DPBB verwendet. Die Heilungsdauer wurde entsprechend von 5 auf 8 Monate erhöht. Zum Zeitpunkt der Implantatsetzung wurden insgesamt 20 vertikale Biopsien entnommen und für die Histomorphometrie als nicht-entkalkte, Goldner-gefärbte Schnitte verwendet. Ergebnisse: Die Ergebnisse zeigten in allen Fällen, dass die DPBB-Granula über Brücken von vitalem neu gebildetem Knochen miteinander verbunden waren. Das Volumen des Knochens in dem transplantiertem Gebiet korrelierte umgekehrt mit der Konzentration der transpantierten DPBB und variierte zwischen 37% und 23%. Jedoch lag das Gesamtvolumen des mineralisierten Materials (Knochen+DPBB-Granula)bei allen 5 Patienten im selben Bereich (zwischen 53% und 59%). Die hohen Werte für Ostoid und Resorptionsflächen sowie die Anwesenheit von TRAP-positiven multinukleären Osteoklasten in Resorptionslakunen, zeigte, dass das Knochenremodelling in allen Transplantaten sehr aktiv war. Auch in flachen Resorpionsgrübchen auf der DPBB-Oberfläche wurden Osteoklasten beobachtet. Der Prozentsatz der DPBB-Oberfläche welche im Knochenkontakt war blieb mit etwa 35% stabil und korrelierte nicht mit dem Anteil des transplantierten DPBBs. Schlussfolgerung:Obwohl die untersuchte Patientenzahl sehr gering ist, lassen die Daten vermuten, dass Ent-Proteinisierter spöngiöser boviner Knochen, vorzugsweise mit autogenen Knochenpartikeln kombiniert, ein geeignetes Material für die Sinusboden-Elevation bei stark atrophischer Maxilla ist. Résumé Os bovin spongieux déprotéiné comme substitut osseux dans l'épaississement sinusal. Une étude histomorphométrique rétrospective de cinq cas Le but de cette étude a été d'analyser en détail les performances de l'os bovin spongieux déprotéiné (DPBB, Bio-Oss®) en granules comme substitut osseux par une analyse histomorphométrique effectuée chez cinq patients traités pour une reconstruction au niveau d'un maxillaire sévèrement atrophié. DPBB a été utilisé en mélange avec des particules osseuses autogènes en concentrations augmentaient de 20 à 100% de DPBB, avec un temps de guérison augmentant paralèllement de cinq à huit mois. Vingt biopsies verticales ont ainsi été prélevées au moment du placement des implants et utilisées pour l'histomorphométrie sur coupes colorées Goldner non-décalcifiées. Les résultats ont indiqué que dans tous les cas les granules DPBB ont été interconnectées par des bridges d'os néoformé vivant. Le volume d'os dans l'aire greffée était en corrélation inverse avec les concentrations de DPBB greffées et variait entre 37 et 23 %. Cependant le volume total de matériel minéralisé (os+granules DPBB) restait dans les mêmes moyennes chez les cinq patients (entre 53 et 59 %). Les valeurs importantes pour la surface de résorption et ostéides, et la présence d'ostéoclastes multinucléaires positifs au TRAP dans les lacunes de résorption indiquaient que le remodelage osseux était très actif dans tous les greffons. Les ostéoclastes étaient également observés dans des petites crevasses de résorption étroites sur les surfaces DPBB. Le pourcentage DPBB en contact avec l'os demeurait stable à environ 35% et ne pouvait pas être mis en relation avec la proportion de DPBB greffé. Bien que le nombre de patients examinés aie été très limité, les données suggèrent que l'os bovin spongieux déprotéiné de préférence en combinaison avec des particules d'os autogène est un bon matériel pour l'épaississement du plancher sinusal en présence de maxillaire humain sévèrement atrophié. [source]


    Healing patterns in calvarial bone defects following guided bone regeneration in rats

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 9 2002
    A micro-CT scan analysis
    Abstract Objective: The objective of this study was to evaluate healing patterns of critical-size calvarial bone defects treated according to principles of guided bone regeneration using micro-CT scan analysis. Specifically, the contribution of bone, periosteum and dura mater to the amount and mineralization of newly formed bone was evaluated. Material and Methods: Surgically induced, critical-size calvarial bone defects in 48 adult male Wistar rats received the following: an occlusive expanded polytetrafluoroethylene (ePTFE) membrane at the exo- and endocranial aspect (OO; n = 12); an occlusive membrane at the exocranial and a perforated membrane at the endocranial aspect (OP; n = 12); a perforated membrane at the exocranial and an occlusive membrane at the endocranial aspect (PO; n = 12); and a perforated membrane at the exo- and endocranial aspect (PP; n = 12). The animals were euthanized at 4 weeks for quantitative analysis of bone volume fraction and mineralization in the region of interest (ROI) as well as in the external, middle and central area of the defect using micro-CT. Results: Bone volume fraction ranged from 31.4% (OP) to 24.5% (PP). No differences were found among the groups. Bone volume fraction and mineralization in the middle area were significantly greater in group OP than in group PP, and in the central area in group OO and PO than in group PP. Conclusions: The results of this study suggest that use of occlusive ePTFE membranes enhances bone formation and maturation in the calvarial skeleton. When occlusion of endo- and exocranial tissues was compromised by membrane perforation, impaired bone formation and mineralization were observed. [source]


    The effect of a fibrin glue on the integration of Bio-Oss® with bone tissue

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 5 2002
    An experimental study in labrador dogs
    Abstract Background: Bio-Oss® is a deproteinized bovine mineral used in bone augmentation procedures. The particles are often mixed with a protein product (Tisseel®) to form a mouldable graft material. Aim: The aim of the present experiment was to study the healing of self-contained bone defects after the placement of Bio-Oss® particles alone or mixed with Tisseel® in cylindrical defects in the edentulous mandibular ridge of dogs. Material and methods: In 4 labrador dogs, the 2nd, 3rd and 4th mandibular premolars were extracted bilaterally. 3 months later, 3 cylindrical bone defects, 4 mm in diameter and 8 mm in depth, were produced in the right side of the mandible. Following a crestal incision, full thickness flaps were raised and the bone defects were prepared with a trephine drill. The defects were filled with Bio-Oss® (Geistlich Biomaterials, Wolhuser, Switzerland) particles alone or mixed with Tisseel® (Immuno AG, Vienna, Austria), or left "untreated". A collagen membrane (Bio-Gide®, Geistlich Biomaterials, Wolhuser, Switzerland) was placed to cover all defects and the flaps were sutured. 2 months later, the defect preparation and grafting procedures were repeated in the left side of the mandible. After another month, the animals were sacrificed and biopsies obtained from the defect sites. Results: Bio-Oss® -treated defects revealed a higher percentage of contact between graft particles and bone tissue than defects treated with Bio-Oss®+ Tisseel® (15% and 30% at 1 and 3 months versus 0.4% and 8%, respectively). Further, the volume of connective tissue in the Bio-Oss® treated defects decreased from the 1 to the 3 month interval (from 44% to 30%). This soft tissue was replaced with newly formed bone. In the Bio-Oss®+ Tisseel® treated defects, however, the proportion of connective tissue remained unchanged between 1 and 3 months. Conclusion: The adjunct of Tisseel® may jeopardize the integration of Bio-Oss® particles with bone tissue. Zusammenfassung Hintergrund: Bio-Oss® ist ein entproteiniertes Mineral vom Schwein, was bei knöchernen Augmentationen verwendet wird. Die Partikel werden oft mit einem Proteinprodukt gemischt, um ein formbares Implantationsmaterial zu erhalten. Ziel: Das Ziel des vorliegenden Experimentes war das Studium der Heilung von selbst-erhaltenden Knochendefekten nach der Anwendung von Bio-Oss® Partikeln allein oder vermischt mit Tisseel® in zylindrischen Defekten im zahnlosen unteren Kieferkamm von Hunden. Materal und Methoden: Bei 4 Labradorhunden wurden die 2., 3. und 4. unteren Prämolaren beidseitig extrahiert. 3 Monate später wurden 3 zylindrische Knochendefekte, 4 mm im Durchmesser und 8 mm tief, auf der rechten Seite des Unterkiefers hergestellt. Nach einer krestalen Incision wurde ein voller Mukoperiostlappen mobilisiert und die knöchernen Defekte mit einem Trepanfräser präpariert. Die Defekte wurden mit Bio-Oss® Partikeln (Geistlich Biomaterial, Wolhuser, Schweiz) allen oder gemischt mit Tisseel® (Immuno AG, Wien, Österreich) gefüllt oder blieben "unbehandelt". Eine Kollagenmembran (Bio-Gide®, Geistlich Biomaterial, Wolhuser, Schweiz) wurde zur Abdeckung über alle Defekte gelegt und die Lappen reponiert und vernäht. 2 Monate später wurden die Defektpräparationen und die Implantationsmaßnahmen auf der linken Seite des Unterkiefers widerholt. Nach einem weiteren Monat wurden die Tiere getötet und Biopsien von den Defektseiten gewonnen. Ergebnisse: Mit Bio-Oss® behandelte Defekte zeigten einen höheren Prozentsatz von Kontakt zwischen Implantationsmaterial und Knochengewebe als die Defekte, die mit Bio-Oss® und Tisseel® behandelt worden waren (15% und 30% zum 1. Monat und 3. Monat versus 0.4% und 8%). Weiterhin verringerte sich das Volumen des Bindegewebes in den mit Bio-Oss® behandelten Defekten vom 1. zum 3. Monat (von 44% zu 30%). Dieses Weichgewebe wurde mit neu gebildetem Knochen ersetzt. In dem mit Bio-Oss® und Tisseel® behandelten Defekten blieb die Verteilung des Bindegewebes zwischen dem 1. und 3. Monat unverändert. Zusammenfassung: Die Zugabe von Tisseel® kann die Integration von Bio-Oss® Partikeln mit Knochengewebe behindern. Résumé Origine: Le Bio-Oss® est un minéral bovin déprotéine utilisé pour les épaississements osseux. Les particules sont souvent mélangées avec un produit protéiné (Tisseel®) pour former un matérial de greffe malléable. But. Le but de l'étude présente a été d'étudier la guérison des lésions osseuses après le placement de particules de Bio-Oss® seules ou mélangées au Tisseel® dans des lésions cylindriques au niveau de la mandibule édentée de labradors. Matériaux et méthodes: Chez 4 labradors les 2ièmes, 3ièmes et 4ièmes prémolaires inférieures ont été avulsées bilatéralement. 3 mois après, 3 lésions osseuses et cylindriques de 4 mm de diamètre et de 8 mm de profondeur ont été produites du côté droit de la mandibule. A la suite d'une incision crestale, des lambeaux d'épaisseur complète ont été relevés et les lésions osseuses préparées avec un trépan. Les lésions ont été comblées par des particules de Bio-Oss® seul (Geistlich Biomaterials, Wolhuser, Suisse) ou mélangées au Tisseel® (Immuno AG, Vienne) ou laissées non-traitées. Une membrane collagène (Bio-Gide®, Geistlich Biomaterials, Wolhuser, Suisse) a été placée pour recouvrir toutes les lésions et les lambeaux ont ensuite été suturés. 2 mois après, les processus précités ont été répétés au niveau gauche de la mandibule. 1 mois plus tard, les animaux ont été tués et les biopsies prélevées. Résultats: Les lésions traitées par le Bio-Oss® ont révélé un % plus important de contact entre les particules du greffon et le tissu osseux que les lésions traitées avec le Bio-Oss®+Tisseel® (respectivement 15% à 30% à 1 et 3 mois versus 0.4% et 8%). De plus le volume de tissu conjonctif dans les lésions traitées par Bio-Oss® diminuait du mois 1 au mois 3, de 44 à 30%. Ce tissu mou a été remplacé par un os néoformé. Dans les lésions traitées par Bio-Oss®+Tisseel®, la proportion de tissu conjonctif demeurait inchangée entre les mois 1 et 3. Conclusions: L'addition de Tisseel® peut mettre en péril l'intégration des particules de Bio-Oss® au tissu osseux. [source]


    In vivo effects of modification of hydroxyapatite/collagen composites with and without chondroitin sulphate on bone remodeling in the sheep tibia

    JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 1 2009
    Wolfgang Schneiders
    Abstract The addition of chondroitin sulphate (CS) to bone cements with calcium phosphate has lead to an enhancement of bone remodeling and an increase in new bone formation in small animals. The goal of this study was to verify the effect of CS in bone cements in a large animal model simulating a clinically relevant situation of a segmental cortical defect of a critical size on bone,implant interaction and bone remodeling. The influence of adding CS to hydroxyapatite/collagen (HA/Col) composites on host response was assessed in a standard sheep tibia model. A midshaft defect of 3 cm was created in the tibiae of 14 adult female sheep. The defect was filled with a HA/Col cement cylinder in seven animals and with a CS-modified hydroxyapatite/collagen (HA/Col/CS) cement cylinder in seven animals. In all cases the tibia was stabilized with an interlocked universal tibial nail. The animals in each group were analyzed with X-rays, CT scans, histology, immunohistochemistry, and enzymehistochemistry, as well as histomorphometric measurements. The X-ray investigation showed a significantly earlier callus reaction around the HA/Col/CS implants compared to HA/Col alone. The amount of newly formed bone at the end point of the experiment was significantly larger around HA/Col/CS cylinders both in the CT scan and in the histomorphometric analysis. There were still TRAP-positive osteoclasts around the HA/Col implants after 3 months. The number of osteopontin-positive osteoblasts and the direct bone contact were significantly higher around HA/Col/CS implants. We conclude that addition of CS enhances bone remodeling and new bone formation around HA/Col composites. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:15,21, 2009 [source]


    In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination

    JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 5 2006
    D. Dallari
    Abstract The repair of confined trabecular bone defects in rabbits treated by autologous bone marrow stromal cells (BMSC), platelet-rich plasma (PRP), freeze-dried bone allografts (FDBA) alone and in combination (BMSC,+,PRP; FDBA,+,BMSC; FDBA,+,PRP; FDBA,+,PRP,+,BMSC) was compared. A critical size defect was created in the distal part of the femurs of 48 adult rabbits. Histology and histomorphometry were used in the evaluation of healing at 2, 4, and 12 weeks after surgery. The healing rate (%) was calculated by measuring the residual bone defect area. Architecture of the newly formed bone was compared with that of bone at the same distal femur area of healthy rabbits. The defect healing rate was higher in PRP,+,BMSC, FDBA,+,PRP, FDBA,+,BMSC, and FDBA,+,PRP,+,BMSC treatments, while lower values were achieved with PRP treatment at all experimental times. The highest bone-healing rate at 2 weeks was achieved with FDBA,+,PRP,+,BMSC treatment, which resulted significantly different from PRP (p,<,0.05) and BMSC (p,<,0.05) treatments. At 4 weeks, the bone-healing rate increased except for PRP treatment. Finally, the bone-healing rate of FDBA,+,PRP, FDBA,+,BMSC, and FDBA,+,PRP,+,BMSC was significantly higher than that of PRP at 12 weeks (p,<,0.05). At 12 weeks, significant differences still existed between PRP, BMSC, and FDBA groups and normal bone (p,<,0.05). These results showed that the combination of FDBA, BMSC and PRP permitted an acceleration in bone healing and bone remodeling processes. © 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res [source]


    The Effect of a Constant Electrical Field on Osseointegration after Immediate Implantation in Dog Mandibles: A Preliminary Study

    JOURNAL OF PROSTHODONTICS, Issue 5 2007
    Yadollah Soleymani Shayesteh DDS
    Purpose: The long time span between insertion of implants and functional rehabilitation often inconveniences patients. Accelerating bone growth around dental implants can shorten this time span. This in vivo study evaluated the effect of a constant electrical field on bone growth around dental implants. Materials and Methods: Four mongrel dogs were used in this study. Sixteen dental implants were placed immediately after extraction of the first premolar and molar teeth. A constant electrical field (CEF) generator was placed in the mucoperiostal pouch created from the subperiostral dissection under the inferior border of the dog's mandible and connected to the experiment side fixtures. CEF provided 3 V of electrical potential during osseointegration. Histologic sections were stained with hematoxylin,eosin and observed under light microscopy. The sections were analyzed histomorphometrically to calculate the amount of newly formed bone. Statistical analysis was performed with SPSS 11.0 computer software (,= 0.05). Results: At the end of the first stage of the osseointegration (90 days) CEF group sections showed enhanced growth of the trabeculae compared with the control group. Statistical analysis revealed significant differences between experimental and control groups. Bone contact ratio was statistically significant in the experimental group (p= 0.001). An increase in the local bone formation and bone contact ratio was observed with direct electrical stimulation of the implant and the bone area around the implant. Conclusion: Minimal direct electrical current, which can produce an electrical field around the implant, can increase the amount of bone formation and decrease the time of osseointegration. [source]


    Histological evaluation on bone regeneration of dental implant placement sites grafted with a self-setting ,-tricalcium phosphate cement

    MICROSCOPY RESEARCH AND TECHNIQUE, Issue 2 2008
    Masayoshi Nakadate
    Abstract This study aimed to evaluate the histological characteristics of the new bone formed at dental implant placement sites concomitantly grafted with a self-setting tricalcium phosphate cement (BIOPEX-R®). Standardized defects were created adjacent to the implants in maxillae of 4-week-old male Wistar rats, and were concomitantly filled with BIOPEX-R®. Osteogenesis was examined in two sites of extreme clinical relevance: (1) the BIOPEX-R®-grafted surface corresponding to the previous alveolar ridge (alveolar ridge area), and (2) the interface between the grafting material and implants (interface area). At the alveolar ridge area, many tartrate-resistant acid phosphatase (TRAPase)-reactive osteoclasts had accumulated on the BIOPEX-R® surface and were shown to migrate toward the implant. After that, alkaline phosphatase (ALPase)-positive osteoblasts deposited new bone matrix, demonstrating their coupling with osteoclasts. On the other hand, the interface area showed several osteoclasts initially invading the narrow gap between the implant and graft material. Again, ALPase-positive osteoblasts were shown to couple with osteoclasts, having deposited new bone matrix after bone resorption. Transmission electron microscopic observations revealed direct contact between the implant and the new bone at the interface area, although few thin cells could still be identified. At both the alveolar ridge and the interface areas, newly formed bone resembled compact bone histologically. Also, concentrations of Ca, P, and Mg were much alike with those of the preexistent cortical bone. In summary, when dental implant placement and grafting with BIOPEX-R® are done concomitantly, the result is a new bone that resembles compact bone, an ideal achievement in reconstructive procedures for dental implantology. Microsc. Res. Tech., 2008. © 2007 Wiley-Liss, Inc. [source]


    Expression of bone morphogenetic proteins in colon carcinoma with heterotopic ossification

    PATHOLOGY INTERNATIONAL, Issue 8 2001
    Nobuhiro Imai
    Here we report the case of a 50-year-old woman with adenocarcinoma of the colon, showing heterotopic ossification. The patient was referred to our hospital for investigation of anemia secondary to occult gastrointestinal blood loss. By colonoscopy, an irregular polypoid mass was found in the ascending colon. A biopsy of the lesion revealed moderately to poorly differentiated adenocarcinoma with heterotopic ossification. A right hemicolectomy was done and revealed areas of heterotopic bone within the tumor, but no ossification was evident in the metastatic lesions within the mesenteric lymph nodes. The formation of heterotopic bone in gastrointestinal tumors is rare and its exact mechanism is unknown. Immunohistochemical localization of bone morphogenetic proteins (BMP), known to be primary inducers of new bone formation, was determined. BMP-5 and -6 were prominent in the cytoplasm of tumor cells, and they stained weakly in osteoblast-like cells adjacent to newly formed bone. Cytoplasmic staining for BMP-2 and -4 was weak in tumor cells, osteoblast-like cells, and stromal fibroblast cells. BMP may play an important role in heterotopic ossification in colon adenocarcinoma. [source]


    Enhanced Bone Bonding of the Hydroxyapatite/,-Tricalcium Phosphate Composite by Electrical Polarization in Rabbit Long Bone

    ARTIFICIAL ORGANS, Issue 6 2010
    Hideki Sagawa
    Abstract A review of the osteogenic cell activity and new bone growth in the regions bordering negatively charged surfaces of polarized Hydroxyapatite/,-tricalcium phosphate (HA/TCP) composites implanted in the long bone in rabbits was conducted. Polarized and non-polarized HA/TCP specimens were implanted into the right and left femoral condyle, respectively (each n = 10). After 3 and 6 weeks, five rabbits were sacrificed in each group, and histological analysis was administered. Large cuboidal-shaped osteoblastic cells were predominantly observed lining the newly formed bone on the negatively charged surface (N-surface) in the polarized HA/TCP implants. The TRAP-positive multinucleated cells were observed extensively in the newly formed bone on the N-surfaces compared with the 0-surface and adhered directly to the HA/TCP composite. The bone area (B.Ar) value, newly formed bone area contacting the implant, and contact length (C.Le) value, percentage length of newly formed bone directly attaching to the implant, on both the 0- and N-surface increased significantly with time in each group. Both the B.Ar and C.Le value on the N-surface were significantly greater than those on the 0-surface after 3 and 6 weeks. The number of TRAP-positive cells/total length value on the N-surface was significantly greater than that on the 0-surface after 3 and 6 weeks postoperatively. It is hypothesized that electrical charge acquired by electrical polarization treatment may modify the biochemical and biophysical processes of the osteogenic cells, resulting in enhanced new bone formation and direct bonding between the recipient bone and implants. [source]


    Combining Scaffolds and Osteogenic Cells in Regenerative Bone Surgery: A Preliminary Histological Report in Human Maxillary Sinus Augmentation

    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 2009
    Carlo Mangano DDS
    ABSTRACT Purpose: The following case series evaluated the maxillary sinus augmentation responses to tissue-engineered bone graft obtained by a culture of autogenous osteoblasts seeded on polyglycolic,polylactic scaffolds and calcium phosphate. Materials and Methods: Sinus floor augmentation was performed bilaterally in five patients (mean age 58.4 years) with tissue-engineered bone (test site , Oral Bone®, BioTissue, Freiburg, Germany) or calcium phosphate (control site , Biocoral, Novaxa Spa, Milan, Italy). Biopsies were harvested 6 months after sinus augmentation for histometric evaluation. Volumetric measurements were taken at baseline and 6 months after the surgical procedure. Results: The mean of vertical bone gain was 6.47 ± 1.39 mm and 9.14 ± 1.19 mm to test and control sites, respectively. The histological sections depicted mature bone with compact and cancellous areas. All biopsies contained varying percentages of newly formed bone and marrow spaces. The mean of bone tissue in the grafted area was 37.32 ± 19.59% and 54.65 ± 21.17% for tissue-engineered bone and calcium phosphate, respectively. Conclusion: Within the limits of the present report, the histological data in humans confirmed that tissue-engineered bone and calcium phosphate allowed newly formed bone after maxillary sinus augmentation. [source]


    Alveolar Ridge Regeneration with Equine Spongy Bone: A Clinical, Histological, and Immunohistochemical Case Series

    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 2 2009
    Danilo Alessio Di Stefano DDS
    ABSTRACT Background: In the case of localized ridge atrophy, a ridge augmentation procedure, with the use of bone substitutes and barrier membranes, may then be necessary. Purpose: The aim of the present study was a clinical, histological, and immunohistochemical evaluation of an equine spongy bone in alveolar ridge augmentation procedures. Materials and Methods: Five patients showing horizontal mandibular ridge defects participated in this study. A ridge augmentation was performed through an onlay apposition of equine bone covered by a titanium-reinforced membrane. After 6 months of healing, five bone cores from nonaugmented sites (control) and five from augmented sites (test) were retrieved. Results: In test sites, no postoperative complications occurred. Horizontal bone width increased from ,4 to ,7 mm. In control sites, the newly formed bone represented 33%, and in test sites, 35% of the total area. The mean value of the microvessel density was 25.6 +/, 3.425 per mm2 in controls, while 33.3 +/, 2.5 vessels per mm2 in the test sites were found (p < .05). Both groups showed a high intensity (++) of vascular endothelial growth factor expression in the newly formed bone, while a low intensity (+) was found in the mature bone. Conclusion: Equine bone appeared to be biocompatible and to be associated with new vessel ingrowth. Within the limits of the small sample size, the present study indicated that equine bone could be used in mandibular ridge augmentations. [source]


    Anchorage of Titanium Implants with Different Surface Characteristics: An Experimental Study in Rabbits

    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 3 2000
    Klaus Gotfredsen DDS
    ABSTRACT Purpose: To compare the anchorage of titanium implants with different surface roughness and topography and to examine histologically the peri-implant bone after implant removal. Materials and Methods: Screw implants with five different surface topographies were examined: (1) turned ("machined"), (2) TiO2 -blasted with particles of grain size 10 to 53 ,m; (3) TiO2 -blasted, grain size 63 to 90 ,m; (4) TiO2 -blasted, grain size 90 to 125 ,m; (5) titanium plasma-sprayed (TPS). The surface topography was determined by the use of an optical instrument. Twelve rabbits, divided into two groups, had a total of 120 implants inserted in the tibiae. One implant from each of the five surface categories was placed within the left tibia of each rabbit. By a second operation, implants were installed in the right tibia, after 2 weeks in group A and after 3 weeks in group B. Fluorochrome labeling was performed after 1 and 3 weeks. Removal torque (RMT) tests of the implants were performed 4 weeks after the second surgery in group A and 9 weeks after the second surgery in group B. Thus, in group A, two healing groups were created, representing 4 and 6 weeks, respectively. The corresponding healing groups in group B were 9 and 12 weeks. The tibiae were removed, and each implant site was dissected, fixed, and embedded in light-curing resin. Ground sections were made, and the peri-implant bone was analyzed using fluorescence and light microscopy. Results: The turned implants had the lowest Sa and Sy values, whereas the highest scores were recorded for the TPS implants. The corresponding Sa and Sy values for the TiO2 -blasted implants were higher when a larger size of grain particles had been used for blasting. At all four observation intervals, the TPS implants had the highest and the turned implants the lowest RMT scores. The differences between the various TiO2 -blasted implants were, in general, small, but the screws with the largest Sa value had higher RMT scores at 6, 9, and 12 weeks than implants with lower Sa values. The histologic analysis of the sections representing 6, 9, and 12 weeks revealed that fractures or ruptures were present in the marginal, cortical peri-implant bone. In such sections representing the TPS and TiO2 -blasted implant categories, ruptures were frequently found in the zone between the old bone and the newly formed bone, as well as within the newly formed bone. Conclusions: The present study demonstrated that a clear relation exists between surface roughness, described in Sa values, and implant anchorage assessed by RMT measurements. The anchorage appeared to increase with the maturation of bone tissue during healing. [source]


    Transmucosal healing around peri-implant defects: crestal and subcrestal implant placement in dogs

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 8 2010
    Binh L. T. Tran
    Abstract Objective: This study was designed to evaluate the transmucosal healing response of implants placed with the junction of the smooth surfaces, either crestal or subcrestal, into simulated extraction defects after healing periods of 1 and 3 months. Materials and methods: A total of 23 Straumann SP ,3.3 mm NN, SLA® 10 mm implants were placed in the mandibular premolar regions of three greyhound dogs 3 months after the teeth were removed. Five control implants were placed at the crestal bone level, and test implants with surgically created peri-implant defects of 1.25 mm wide × 5 mm depth were placed either at the crestal (nine implants) or at the 2 mm subcrestal (nine implants) bone level. Implants on the right side were placed 1 month before the dogs were sacrificed, and implants on the left side were placed 3 months before sacrifice. All dogs had daily plaque control following surgery and were sacrificed 3 months after implant placement for histological and histometric analyses. Results: Mesial,distal ground sections of the control and test implant specimens showed a greater %BIC in the coronal defect region after 3 months of healing. This healing response was incomplete for the test implants compared with the control implants after a 1-month healing period. The histometric measurements for test implants placed at the crestal bone level or 2 mm subcrestal with surgically created peri-implant defects were more coronal or closer to the implant margin compared with the control implants. Additionally, the degree of osseointegration between the newly formed bone and the implant surface was similar between the test implants. Conclusion: Peri-implant defects of 1.25 mm width healed with spontaneous bone regeneration around implants placed transmucosally at crestal or 2 mm subcrestal with a high degree of osseointegration after a 3-month healing period. To cite this article: Tran BLT, Chen ST, Caiafa A, Davies HMS, Darby IB. Transmucosal healing around peri-implant defects: crestal and subcrestal implant placement in dogs. Clin. Oral Impl. Res. 21, 2010; 794,803. doi: 10.1111/j.1600-0501.2010.01911.x [source]


    Healing of rabbit calvarial bone defects using biphasic calcium phosphate ceramics made of submicron-sized grains with a hierarchical pore structure

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 3 2010
    Jin-Woo Park
    Abstract Objectives: This study investigated the efficacy of new bone graft substitutes , biphasic calcium phosphates (BCP) made of submicron-sized grains with fully interconnected wide-range micron-scale pores in two different macrodesigns: donut shaped with a 300,400 ,m central macropore (n-BCP-1) or rod-shaped (n-BCP-2) , in the healing of rabbit calvarial defects, and compared their bone-healing properties with those of various commercial bone substitutes, which included substitutes with similar BCP composition (MBCP and Osteon), anorganic bovine bone (Bio-Oss), and ,-TCP (Cerasorb). Material and methods: The surface morphology of the bone substitutes was investigated using scanning electron microscopy (SEM). Defects 8 mm in diameter were created in the calvaria of 30 adult male New Zealand White rabbits and were filled with six types of bone substitutes. The percentage of newly formed bone (NB%) was evaluated histomorphometrically 4 and 8 weeks after implantation. Results: SEM observation showed submicron-sized grains with fully interconnected micropore structures in the n-BCP-1 and n-BCP-2 groups; these groups also showed considerable new bone formation in inner micropores as well as on the outer surfaces. The n-BCP-1 group exhibited enhanced new bone formation and direct ingrowth of bone tissue with blood vessels into central pores. Histomorphometric analysis showed significantly greater NB% in the n-BCP-1 group when compared with the other groups at 4 and 8 weeks (P<0.05). Conclusion: A new BCP ceramics made of submicron-sized grains with a hierarchical pore structure was an effective osteoconductive material for the treatment of osseous defects of rabbit calvaria. To cite this article: Park J-W, Kim E-S, Jang J-H, Suh J-Y, Park K-B, Hanawa T. Healing of rabbit calvarial bone defects using biphasic calcium phosphate ceramics made of submicron-sized grains with a hierarchical pore structure. Clin. Oral Impl. Res. 21, 2010; 268,276. doi: 10.1111/j.1600-0501.2009.01846.x [source]


    The use of autologous venous blood for maxillary sinus floor augmentation in conjunction with sinus membrane elevation: an experimental study

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 3 2010
    Ha-Rang Kim
    Abstract Background: There have been reports of successful bone formation with sinus floor elevation induced by simply elevating the maxillary sinus membrane and filling the sinus cavity with a blood clot. Purpose: We investigated the feasibility of maxillary sinus floor augmentation using the patient's own venous blood in conjunction with a sinus membrane elevation procedure. Materials and methods: An implant that protruded 8 mm into the maxillary sinus after sinus membrane elevation was placed in the maxillary sinus of six adult female mongrel dogs. The resulting space between the membrane and the sinus floor was filled with autologous venous blood retrieved from each dog. The implants were left in place for 6 months. Results: During the experimental period, the created space collapsed and the sinus membrane fell down onto the implant. A small amount of new bone formation occurred in the space created by the collapsed membrane. The average height of newly formed bone around the implants in the sinus was 2.7±0.7 mm on the buccal side and 0.6±0.3 mm on the palatal side. Conclusion: The results of this pilot study indicate that blood clots do not have sufficient integrity to enable the sinus membrane to remain in an elevated position for therapeutically effective periods of time. Accordingly, it is recommended that this method be used only when a small aount of new bone formation is necessary around implants in the maxillary sinus cavity. To cite this article: Kim H-R, Choi B-H, Xuan F, Jeong S-M. The use of autologous venous blood for maxillary sinus floor augmentation in conjunction with sinus membrane elevation: an experimental study. Clin. Oral Impl. Res. 21, 2010; 346,349. doi: 10.1111/j.1600-0501.2009.01855.x [source]


    Vertical bone augmentation with fluvastatin in an injectable delivery system: a rat study

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 8 2009
    Yohei Jinno
    Abstract Objectives: HMG-CoA reductase inhibitors (statins) are widely used for hyperlipidemia. Previous studies demonstrate that statins stimulate bone morphogenetic protein-2 (BMP-2) expression and lead to bone formation. The aim of this study was to evaluate whether percutaneously injected statin with a novel statin delivery system achieved vertical bone augmentation. Material and methods: As experimental groups, atelocollagen-,-tricalcium phosphate (,TCP) composites containing 3.3 mg (low dose) or 6.7 mg (high dose) of fluvastatin were injected (one shot) subcutaneously over the calvarial periosteum of rats. The animals were then sacrificed 1, 2, and 4 weeks after injection. Vertically augmented bone was assessed by histomorphometric procedures, i.e., by measuring new bone thickness (NBT) and bone density (BD). Results: In control groups, no newly formed bone could be seen over the calvarial bone. In the experimental groups, in contrast, a large amount of newly formed bone could be seen over the preexisting calvarial bone. The newly formed bone was seen to be in direct contact with the preexisting bone. During the entire observation, significant NBT was observed in the experimental groups (P<0.05). At the final stage of observation (4 weeks), NBT was 66.7% (low-dose group) and 59.7% (high-dose group), while they were from 1% to 16.3% in the control groups. In the experimental groups, BD significantly increased in a time-dependent manner. Conclusion: Percutaneously applied fluvastatin (one shot) with a composite of ,TCP and collagen has great potential to augment the height of the bone. [source]


    Bone repair and augmentation using block of sintered bovine-derived anorganic bone graft in cranial bone defect model

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 4 2009
    Tania Mary Cestari
    Abstract Objective: To histomorphometrically investigate the repair of critical size defects (CSDs) and bone augmentation in cranial walls using block of sintered bovine-derived anorganic bone (sBDAB) graft. Material and methods: Forty guinea-pigs were divided into test (n=20) and CSD control (n=20) groups. In each animal, a full-thickness bone defect with 9.5 mm diameter was made in the frontal bone. The defects were filled with an sBDAB block soaked in blood in the test group and with blood clot in the CSD control group. The skulls were collected at 0 h (n=2) and 30, 90 and 180 days (n=6/group and period) postoperatively. The volume density and total volume of newly formed bone, sBDAB, blood vessels and connective tissue, vertical thickness of removed bone plug, sBDAB block and graft area were evaluated. Results: The vertical thickness of the adapted sBDAB block was 3.8 times higher than that of the removed bone plug and did not show significant difference between periods, filling in average 29.8% of the total graft region. The sBDAB block exhibited complete osseointegration with the borders of the defect at 90 days. At 90 and 180 days, the vertical thickness of the graft was 279% in the average, and the total volume of bone augmentation was, respectively, 78.8% and 148.5% higher compared with the removed bone plug. The defects of the CDS control group showed limited osteogenesis and filling by connective tissue plus tegument. Conclusion: The sBDAB block can be used to promote repair of CSDs and bone augmentation in the craniomaxillofacial region, due to its good osteoconductive and slow resorptive properties. [source]


    Evaluation of a new biodegradable membrane to prevent gingival ingrowth into mandibular bone defects in minipigs

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 1 2009
    Daniel S. Thoma
    Abstract Objective: The aim of this study was to test whether a synthetic, biodegradable membrane made of polyethylene glycol (PEG) can prevent soft-tissue ingrowth into alveolar defects. Material and methods: In each of 16 minipigs, three mandibular premolars were bilaterally extracted. Three months later, acute standardized defects (diameter 8 mm, depth 8 mm) were prepared. Four treatment modalities were randomly allocated to the defects: (1) PEG membrane plus collagen sponge, (2) polylactide (PLA) membrane plus collagen sponge, (3) collagen sponge alone, and (4) empty defect. Animals were sacrificed at 10 days (n=5), 21 days (n=5), or 2 months (n=6) after treatment. Qualitative and quantitative histological evaluations of soft-tissue ingrowth and bone regeneration were performed on nondecalcified ground sections. For statistical analysis, the Mann,Whitney,Wilcoxon test, the Kruskal,Wallis, and the paired t -test were applied. P -values were adjusted using the Dunnett,Hsu adjustment. Results: At 10 days, the PEG membrane group showed the least soft-tissue ingrowth (mean value ,0.75 mm; range ,1.35 to ,0.10), followed by the PLA membrane group ,0.18 mm (,0.80 to 0.44), the collagen group 0.04 mm (,0.65 to 0.73), and the empty defects 0.60 mm (,0.08 to 1.29). Statistically significant differences were observed between the PEG membrane group and the empty defects (P<0.05). At 21 days, the highest percentage of newly formed bone was found in the PEG membrane group (mean 28.4%; range 21.6,35.2) compared with 23.7% (16.9,30.5; PLA membrane), 15.2% (8.2,22.2; collagen group), and 21.6% (14.5,28.8; empty defects). Statistically significant differences were only found between the PEG membrane group and the collagen group (P<0.05). At 2 months, the tested parameters revealed no statistically significant differences between the groups. Conclusion: The experimental PEG membrane applied in the present study successfully prevented collapse of the covering soft tissues to a degree similar to the PLA membrane. The combination of a collagen sponge and the PEG membrane showed the least soft-tissue ingrowth at 10 days and promoted more bone formation at 21 days. [source]


    Injectable calcium phosphate cement as a graft material for maxillary sinus augmentation: an experimental pilot study

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 6 2008
    Ali Aral
    Abstract Objectives: The aim of the present study was to evaluate the efficiency of injectable CaP cement as a graft material around dental implants in the maxillary sinus augmentation procedure. Material and methods: Bilateral sinus augmentation process was carried out in three sheep and two implants were inserted during the same session. Out of a total of 12 installed implants, eight belonged to the so-called experimental group. In the experimental group, injectable CaP cement was used as augmentation material while autologous bone served as control. Results: Histological examination revealed that newly formed bone surrounded the cement completely without an intervening fibrous tissue layer. Following a healing period of 12 weeks, mean bone-to-implant contact (BIC) values in the experimental and control groups were 36±5 and 37±3, respectively. The percentage of BIC was comparable with other experimental sinus augmentation studies. Further, it appeared that the thickness of the cortical bone that covered the outer surface of the maxillary sinus was <2,3 mm, which affected the primary stability of the implants negatively. Conclusion: CaP cement is indeed effective to stimulate bone formation in the sinus elevation procedure. Nevertheless, additional improvements in the cement composition are required to allow final clinical utilization of the material. [source]


    Bone apposition around two different sandblasted and acid-etched titanium implant surfaces: a histomorphometric study in canine mandibles

    CLINICAL ORAL IMPLANTS RESEARCH, Issue 3 2008
    Michael M. Bornstein
    Abstract Purpose: The aim of this study was to evaluate bone apposition to a modified sandblasted and acid-etched (SLA) implant surface (modSLA) in the canine mandible as compared with the standard SLA surface. Material and methods: In this experimental study, all mandibular premolars and first molars were extracted bilaterally in five foxhounds. After a healing period of 6 months, each side of the mandible received six randomly assigned dental implants alternating between the standard SLA and modSLA surface. The dogs were sacrificed at 2 weeks (n=2) or 4 weeks (n=3) after implant placement. Histologic and histomorphometric analyses were then performed for each implant. Results: The microscopic healing patterns at weeks 2 and 4 for the two implant types with the standard SLA and modSLA surfaces showed similar qualitative findings. New bone tissue had already established direct contact with implant surfaces after 2 weeks of healing. The mean percentage of newly formed bone in contact with the implant (BIC) was significantly greater for modSLA (28.2±7.9%) than for SLA (22.2±7.3%) (P<0.05). This difference was no longer evident after 4 weeks. An increase in BIC for both implant surface types occurred from weeks 2 to 4. This increase was statistically significant when compared with SLA at 2 weeks (P<0.05), but not when compared with modSLA at 2 weeks. Conclusion: The data from the present study demonstrate significantly more bone apposition for the modSLA surface than the standard SLA surface after 2 weeks of healing. This increased bone apposition may allow a further reduction of the healing period following implant placement for patients undergoing early loading procedures. [source]